Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study
প্রধান লেখক: | , , , , , , , , , , , , , , , , , , |
---|---|
বিন্যাস: | Conference item |
ভাষা: | English |
প্রকাশিত: |
American Society of Clinical Oncology
2020
|